Dihomo-?-Linolenic Acid-d<sub>6</sub>

Dihomo-?-Linolenic Acid-d6

CAT N°: 10458
Price:

From 55.00 46.75

Dihomo-?-Linolenic Acid-d6 (DGLA-d6) is intended for use as an internal standard for the quantification of DGLA (Item No. 90230) by GC- or LC-MS. DGLA (20:3), an elongation product of ?-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, (PGs), including PGE1.{2244,10906} In mice, DGLA supplementation in the diet can reduce atopic dermatitis and atherosclerosis.{19739,19738}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 8Z,11Z,14Z-eicosatrienoic-8,9,11,12,14,15-d6 acid
  • Correlated keywords
    • deuterated LC/MS GC-MS LC-MS mass spectrometry polyunsaturated dihomo-g-linolenic dihomo-?-linolenic dihomo-gamma-linolenic omega-6 ?-6 fatty acids antagonists arachidonic receptors LTB4 deuterium
  • Product Overview:
    Dihomo-?-Linolenic Acid-d6 (DGLA-d6) is intended for use as an internal standard for the quantification of DGLA (Item No. 90230) by GC- or LC-MS. DGLA (20:3), an elongation product of ?-linolenic acid (18:3), is rapidly metabolized by fatty acid desaturases to produce arachidonic acid (20:4). DGLA is metabolized through the cyclooxygenase pathway to produce 1-series prostaglandins, (PGs), including PGE1.{2244,10906} In mice, DGLA supplementation in the diet can reduce atopic dermatitis and atherosclerosis.{19739,19738}

We also advise you